DRKS00023108已完成不适用
on-invasive micro-RNA-based breast cancer diagnostics (Mammacheck) - Mammacheck
Prof. Dr. Thalia ErbesUniversitätsklinikum FreiburgKlinik für Frauenheilkunde0 个研究点目标入组 2,004 人开始时间: 2020年12月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,004
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •Confirmed diagnosis of a primary, non pretreated breast cancer
- •- female sex
- •- signed declaration of consent
- •- >18 years old
- •Comparison test subjects:
- •- >18 years old
- •- female sex
- •- signed declaration of consent
排除标准
- •Age: <18 years
- •- Condition after breast cancer disease
- •- Pregnancy
- •- Acute infections
- •Participation in a drug study within the last 3 months (exclusion by corresponding passage in the declaration of consent)
研究者
相似试验
招募中
不适用
An In-situ Detection for MicroRNABreast CancerNCT06529614Tongji Hospital100
已完成
不适用
earch for developing the breast cancer diagnostic method using photoacoustic mammographyBreast cancerJPRN-UMIN000003406Graduate School of Medicine Kyoto University40
进行中（未招募）
不适用
Breast cancer biomarkers and treatment targetsMalignant neoplasm of breastBreast cancerCancerISRCTN40576403niversity Hospital Southampton (UK)500
已完成
不适用
on-invasive nodal staging in breast cancer with MRI Lymphography using gadofosveset; a pilot- study.Lymph node metastases10006291Breast cancerNL-OMON36702Medisch Universitair Ziekenhuis Maastricht10
已完成
不适用
on-invasive monitoring of breast cancer therapy using circulating tumor DNA from peripheral bloodMetastatic breast cancerNL-OMON43952Erasmus MC, Universitair Medisch Centrum Rotterdam90